Mirtazapine Tablet, Film Coated
Product Images NDC 71610-115

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 15 mg (71610 0115 15)

Label for Mirtazapine 15 mg film-coated tablets, containing 15 tablets. The label includes storage instructions, manufacturer information (Aurobindo Pharma Limited, Hyderabad, India), and repackager details (Aphena Pharma Solutions, Tennessee). The product is for RX only and is identified by NDC 71610-0115-15.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure of Mirtazapine, illustrating the arrangement of its interconnected rings and nitrogen atoms as part of its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.